This article explores sensitivity vs specificity in in vitro diagnostics, and how balancing both is critical for test performance, diagnostic accuracy, and reliable clinical decisions.
This article explains why organisations outsource immunoassay and ELISA development to gain specialist expertise, improve efficiency, reduce costs, and accelerate product development.